Open AccessThe Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARS-CoV 2 Pneumonia
Author(s) -
Ayşe Batırel,
Selda Tekin,
Halit Batırel,
Çiğdem Akalan Kuyumcu,
Nurten Bakan
Publication year - 2021
Publication title -
mediterranean journal of infection, microbes and antimicrobials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.121
H-Index - 1
ISSN - 2147-673X
DOI - 10.4274/mjima.galenos.2021.2020.8
Subject(s) - medicine , hydroxychloroquine , lopinavir , lopinavir/ritonavir , oxygen therapy , procalcitonin , ritonavir , pneumonia , intensive care unit , retrospective cohort study , hazard ratio , combination therapy , viral load , covid-19 , sepsis , disease , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , confidence interval , infectious disease (medical specialty)